Drug regimen review · Pharmacy Service Deficiencies
Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.
F756 in Washington. Pick another state for the same tag.
Against expectation — 2025
Washington cites F756 more often than its own record predicts
Versus expected share1.06×
1.06 times the share F756 takes of citations nationally.
Share of Washington citations0.84%
Of every deficiency written in Washington in 2025, this is the portion that was F756.
Washington0.84%
National0.79%
Share of all citations that were F756.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Washington surveyors wrote
F756 findings written in Washington, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
K · Immediate jeopardy, patternJune 28, 2021
Based on interview and record review, the facility failed to address Drug Regimen Review (DRR) recommendations for 2 (April and May 2021) of 2 months reviewed. The facility's failure to ensure the DRR recommendations for Resident 1's blood thinning medication was provided to and reviewed by the physician, resulted in Resident 1 suffering a debilitating stroke that left Resident 1 unable to articulate words, formulate ideas, and understand the spoken word. In addition, Resident 1 suffered numbness, tingling, and weakened legs. This failure placed all other residents at risk for harm, related to inappropriate medication dosages, inappropriate drug administration, and/or lack of clinical and/or laboratory monitoring. …
Based on interview and record review, the facility failed to ensure they had effective Medication Regimen Review (MRR) processes for two residents (#4, #34) reviewed. Drug regimen review process reviewed for January to October 2020 for all residents consultant pharmacist had reviewed, inadequate facility response to irregularities, failure to act timely, or at all. The failure: 1) to conduct thorough and timely MRRs, to include failure to do an immediate MRR in a resident that had missed/omitted [MEDICAL CONDITION] medication doses due to staff medication errors that resulted in two hospitalization s, and consultant pharmacist not consulted or notified, 2) to conduct [MEDICAL CONDITION] medication adverse side effects monitoring, not identified by consultant pharmacist, 3) to monitor for… …
D · No harm, potential for more than minimal, isolatedJuly 31, 2026
Based on record review and interview, the facility failed to ensure a pharmacy recommendation for a gradual dose reduction (GDR) was implemented as ordered by the provider for 1 of 5 residents (Resident 49) reviewed for unnecessary medications. This failure placed the resident at risk for receiving unnecessary psychotropic medications and potential adverse drug effects.Finding included.Review of the facility policy titled, Medication Regimen Review, revised date 06/01/2024, documented nursing staff should act upon the recommendations contained within the Medication Regimen Review. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction